Bioline Rx (BLRX) Q2 2022 Earnings Report

3 Followers

IL:BLRX Q2 2022 EPS Results

Actual EPS: -ILA 3.15
Consensus EPS: -ILA 2.84
Beat/Miss: Missed by -ILA 0.32
One Year Ago EPS: -ILA 3.15

IL:BLRX Q2 2022 Revenue Results

Actual Revenue: ILA 0
Expected Revenue: ILA 0
Beat/Miss: Met expectations
YoY Revenue Growth: ―

Earnings Announcement Details

Quarter: Q2 2022
Date: 08/16/2022
Time: Before Open
Conference Call: Tuesday, August 16, 2022

IL:BLRX Upcoming Earnings

Bioline Rx's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

Q2 2022 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

IL:BLRX Earnings History

IL:BLRX earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Nov 18, 2026	2026 (Q3)	-0.32-	0	―	―
Aug 31, 2026	2026 (Q2)	0.000.00	0	―
May 27, 2026	2026 (Q1)	-0.630.00	0	―
Mar 23, 2026	2025 (Q4)	-0.320.00	-0.95	100.00% (+0.95)
Nov 24, 2025	2025 (Q3)	-0.320.00	0	―
Aug 14, 2025	2025 (Q2)	-0.320.00	0	―
May 27, 2025	2025 (Q1)	―-	0	―
Mar 31, 2025	2024 (Q4)	-0.630.00	0	―
Nov 25, 2024	2024 (Q3)	-0.950.00	-6.31	100.00% (+6.31)
Aug 15, 2024	2024 (Q2)	―0.00	-6.31	100.00% (+6.31)
May 28, 2024	2024 (Q1)	―0.00	-3.15	100.00% (+3.15)
Mar 26, 2024	2023 (Q4)	-4.73-4.10	-1.89	-116.67% (-2.21)
Nov 20, 2023	2023 (Q3)	-4.42-6.31	-3.15	-100.00% (-3.15)
Aug 30, 2023	2023 (Q2)	-3.47-6.31	-3.15	-100.00% (-3.15)
May 24, 2023	2023 (Q1)	-2.84-3.15	-3.15	0.00% (+0.00)
Mar 22, 2023	2022 (Q4)	-2.84-1.89	0	―
Nov 15, 2022	2022 (Q3)	-3.47-3.15	-3.15	0.00% (+0.00)
Aug 16, 2022	2022 (Q2)	-2.84-3.15	-3.15	0.00% (+0.00)
May 11, 2022	2022 (Q1)	-3.15-3.15	-6.31	50.00% (+3.15)
Mar 16, 2022	2021 (Q4)	―0.00	-11.98	100.00% (+11.98)
Nov 18, 2021	2021 (Q3)	-2.52-3.15	-6.31	50.00% (+3.15)
Aug 18, 2021	2021 (Q2)	-2.52-3.15	-9.46	66.67% (+6.31)
May 26, 2021	2021 (Q1)	―-6.31	-15.77	60.00% (+9.46)
Feb 23, 2021	2020 (Q4)	―-11.98	-19.87	39.68% (+7.88)
Nov 23, 2020	2020 (Q3)	―-6.31	-18.92	66.67% (+12.62)
Aug 06, 2020	2020 (Q2)	―-9.46	-12.62	25.00% (+3.15)
May 20, 2020	2020 (Q1)	―-15.77	-15.77	0.00% (+0.00)
Mar 12, 2020	2019 (Q4)	―-19.87	-15.77	-26.00% (-4.10)
Nov 11, 2019	2019 (Q3)	―-18.92	-18.92	0.00% (+0.00)
Aug 06, 2019	2019 (Q2)	―-12.62	-15.77	20.00% (+3.15)
May 14, 2019	2019 (Q1)	―-15.77	-18.92	16.67% (+3.15)
Mar 28, 2019	2018 (Q4)	―-15.77	-22.08	28.57% (+6.31)
Nov 08, 2018	2018 (Q3)	―-18.92	-22.08	14.29% (+3.15)
Aug 13, 2018	2018 (Q2)	―-15.77	-15.77	0.00% (+0.00)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Bioline Rx earnings date